Skip to content
10-Q

Quarterly Report

QUANTRX BIOMEDICAL CORPORATION

0001493152-22-031830

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 14, 2022 78.7M sh
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$33.07K
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$34.38K
Cash And Equivalents Q3 2022 · Sep 30, 2022 $3.88K
Cash And Equivalents Q3 2022 · Dec 31, 2021 $5.95K
Stockholders Equity Q3 2022 · Sep 30, 2022 −$2.84M
Stockholders Equity Q3 2022 · Jun 30, 2022 −$2.78M
Stockholders Equity Q3 2022 · Dec 31, 2021 −$2.64M
Stockholders Equity Q3 2022 · Sep 30, 2021 −$2.58M
Stockholders Equity Q3 2022 · Jun 30, 2021 −$2.52M
Stockholders Equity Q3 2022 · Dec 31, 2020 −$2.38M
Total Liabilities Q3 2022 · Sep 30, 2022 $2.85M
Total Liabilities Q3 2022 · Dec 31, 2021 $2.65M
Current Assets Q3 2022 · Sep 30, 2022 $5.38K
Current Assets Q3 2022 · Dec 31, 2021 $5.95K
Total Assets Q3 2022 · Sep 30, 2022 $5.38K
Total Assets Q3 2022 · Dec 31, 2021 $5.95K
Sga Expense Q3 2022 · Sep 30, 2022 $2.9K
Sga Expense Q3 2022 · Sep 30, 2022 $9.51K
Sga Expense Q3 2022 · Sep 30, 2021 $2.81K
Sga Expense Q3 2022 · Sep 30, 2021 $9.46K
Net Income Q3 2022 · Sep 30, 2022 −$61.17K
Net Income Q3 2022 · Sep 30, 2022 −$199.47K
Net Income Q3 2022 · Sep 30, 2021 −$63.02K
Net Income Q3 2022 · Sep 30, 2021 −$199K
Operating Income Q3 2022 · Sep 30, 2022 −$7.25K
Operating Income Q3 2022 · Sep 30, 2022 −$37.76K
Operating Income Q3 2022 · Sep 30, 2021 −$8.54K
Operating Income Q3 2022 · Sep 30, 2021 −$36.82K